1. Evaluation of KI-67 expression in uterine leiomyoma and in healthy myometrium: a pilot study
- Author
-
Walberto Monteiro Neiva Eulálio Filho, Eduardo Augusto Sousa Soares, Maria Simone Oliveira Lima, Emerson Davi do Nascimento Brazil, Rodolfo Myronn de Melo Rodrigues, Rubens Moura Campos Zeron, Benedito Borges Silva, and Pedro Vitor Lopes Costa
- Subjects
Adult ,Medicine (General) ,medicine.medical_specialty ,Anemia ,medicine.medical_treatment ,Miométrio ,Pilot Projects ,Hysterectomy ,Gastroenterology ,Body Mass Index ,03 medical and health sciences ,R5-920 ,0302 clinical medicine ,Reference Values ,Pain level ,Internal medicine ,medicine ,Humans ,030219 obstetrics & reproductive medicine ,Uterine leiomyoma ,Leiomyoma ,biology ,business.industry ,Myometrium ,General Medicine ,medicine.disease ,Immunohistochemistry ,Tumor Burden ,Cross-Sectional Studies ,Ki-67 Antigen ,Case-Control Studies ,030220 oncology & carcinogenesis ,Ki-67 ,Uterine Neoplasms ,biology.protein ,Antígeno KI-67 ,Female ,Leiomioma ,business - Abstract
SUMMARY OBJECTIVE Evaluate the expression of KI-67 in uterine leiomyomas and adjacent myometrial tissue and verify the existence of a correlation between clinical parameters and KI-67 expression in tumors. METHODS This is a cross-sectional, controlled, analytical study. Samples of leiomyomas and myometrium were obtained from patients who underwent hysterectomy. The samples were processed by immunohistochemistry using KI-67 antibody, and the expression was evaluated by two blinded observers. Student›s T-test was used for comparison of means, and Pearson›s P test for correlation with clinical parameters. RESULTS A total of 9 patients were included in the study. The mean age was 40.7 years, ranging from 35 to 44 years. The mean expression of KI-67 in myometrium was 1.63%, and, in leiomyomas, 5.96% (p
- Published
- 2019